LMB:NASDAQLimbach Holdings, Inc. Analysis
Data as of 2026-05-24 - not real-time
$71.36
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Limbach Holdings (LMB) is trading at $71.36, well below its 20‑day, 50‑day and 200‑day SMAs of $82.5, $83.2 and $88.4, indicating a bearish price trend. The RSI of 39.9 hints at near‑oversold conditions, yet the MACD histogram is negative and the signal line is bearish, reinforcing downside momentum. Volume is on a decreasing trend and 30‑day volatility is extreme at 133%, while a beta above 1.3 suggests the stock moves more sharply than the market. Valuation metrics show a trailing PE of 26 versus an industry average of 29.7, but the DCF fair value of $19.4 makes the current price appear overvalued with a 62% upside/downside gap. Forward earnings expectations are brighter, reflected in a forward PE of 14 and a projected EPS of $5.09, supporting a growth narrative. Fundamentals reveal modest revenue growth of 4.3%, a profit margin of 5% and a solid ROE of 18.6%, though operating margins are thin and debt‑to‑equity sits at 38.9%, indicating leverage risk. Recent Q1 2026 results beat revenue forecasts and delivered a non‑GAAP EPS of $0.64, reinforcing the company’s ability to exceed expectations despite a year‑over‑year EPS decline. The firm’s positioning in data‑center infrastructure projects adds a strategic growth catalyst. Overall, the stock balances bearish technical signals with improving earnings outlook and sector‑specific opportunities.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish technical indicators (price below SMAs, negative MACD)
- High volatility and decreasing volume
- Recent earnings beat but EPS decline YoY
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward PE of 14 indicating earnings acceleration
- Strategic exposure to data‑center infrastructure demand
- Solid ROE and profit margin despite thin operating margin
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Overvaluation relative to DCF fair value
- Sustained leverage (debt‑to‑equity ~39%)
- Cyclical nature of building‑products sector
Key Metrics & Analysis
Financial Health
Revenue Growth4.30%
Profit Margin5.09%
P/E Ratio26.0
ROE18.59%
ROA7.78%
Debt/Equity38.95
P/B Ratio4.3
Op. Cash Flow$35.6M
Free Cash Flow$18.6M
Industry P/E29.7
Technical Analysis
TrendBearish
RSI39.9
Support$70.25
Resistance$114.95
MA 20$82.54
MA 50$83.24
MA 200$88.43
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61
Valuation
Fair Value$19.37
Target Price$115.60
Upside/Downside62.00%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.35
Volatility133.21%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.